I propose to take Questions Nos. 290 to 295, inclusive, together.
I am advised by Revenue that it implements customs controls on all goods entering the EU through Irish ports and airports. This involves detecting, intercepting, and seizing prohibited or restricted products, including counterfeit goods, at all points of entry.
Revenue maintains an intelligence-based, risk-focused enforcement presence, deploying over 900 staff across ports, airports, mail centres, supported by inland teams, a maritime unit and intelligence management and profiling teams.
Revenue collaborates closely with An Garda Síochána, the Competition and Consumer Protection Commission (CCPC), and the Health Products Regulatory Authority (HPRA) to combat threats to businesses, consumers, and the Exchequer. Goods suspected of breaching product safety or CE compliance are detained by Revenue and transferred to the CCPC for investigation, who is the competent authority for product safety, specifically in relation to consumer goods and toys.
Revenue’s role is confined to custom control role at ports and airports. Revenue do not hold statistics on cases referred to the CCPC or specific data on children’s toys referred to the CCPC for investigation/destruction.
Revenue advises me that it has no information in relation to any large-scale smuggling of counterfeit goods from Northern Ireland into the State.
Revenue do not seize goods suspected to be counterfeit from local retail premises or markets as it has no statutory power to do so and responsibility for dealing with counterfeit goods that are already present in the State falls to An Garda Síochána.
Revenue’s enforcement role regarding illegal vaping products focuses on e-liquids containing controlled drugs, such as Tetrahydrocannabinol (THC) and Hexahydrocannabinol (HHC), under the Misuse of Drugs Act 1977.
The table below outlines the number of vaping products that contained controlled drugs seized by Revenue from 2024 until the end of August 2026.
|
Year
|
No. of Seizures
|
Volume
|
Value
|
|
2026*
|
307
|
16,268g
|
€310,775
|
|
2025
|
169
|
4,378g
|
€66,247
|
|
2024
|
55
|
3,910g
|
€25,838
|
*As at end of August 2026
Revenue do not have any role in the administration of the retail licensing regime, which is conducted by the public health authorities under legislation introduced by the Minister for Health. Compliance with these regulations is undertaken by the Health Service Executive (HSE) as the market surveillance authority.
Where goods are suspected of infringing an IPR, they are detained pending examination by the rights holder. Where goods are confirmed by the holder of the IPR to be counterfeit, they are detained by Revenue and custody of these items is transferred to the CCPC for further investigation.
The table below provides a breakdown of the number and valuation of counterfeit products detected by Revenue from 2024 to 2026.
|
Year
|
Number
|
Value
|
|
2026*
|
13,887
|
€4.7m
|
|
2025
|
28,202
|
€9.1m
|
|
2024
|
66,445
|
€11.4m
|
* As at end of August 2026